Paper496103
Risk factors for doxorubicin-induced congestive heart failure.
Von Hoff DD and 6 others. Ann Intern Med, 1979. Cited by 2,059 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Risk factors for doxorubicin-induced congestive heart failure. Papers, record 496103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/496103
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Heart Failure | Major topic |
| Adolescent | |
| Adult | |
| Age Factors | |
| Aged | |
| Child | |
| Child, Preschool | |
| Drug Administration Schedule | |
| Electrocardiography | |
| Female | |
| Heart | |
| Humans | |
| Infant | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Risk |
Source PubMed
Trials5
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01708798 | Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer | Background | ClinicalTrials.gov | |
| NCT03000036 | Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients | Background | ClinicalTrials.gov | |
| NCT03342300 | Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma | Background | ClinicalTrials.gov | |
| NCT03930680 | Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane | Background | ClinicalTrials.gov | |
| NCT04213612 | DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors | Background | ClinicalTrials.gov |
Cited by735
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,059 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923061 | Integrated hs-cTnI, global longitudinal strain, and coronary artery calcium for risk stratification of anthracycline-related cardiac dysfunction in multiple myeloma. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42923061 | PubMed |
| 42871672 | Therapy-induced senescence in breast cancer and cardiovascular disease: a double-edged biological process. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42871672 | PubMed |
| 42670080 | Anthracycline Cardiotoxicity: A Real-World Study Based on FDA Adverse Event Reporting System Database. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42670080 | PubMed |
| 42615447 | The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity. | JACC CardioOncol | 2026 | https://conductscience.org/library/papers/42615447 | PubMed |
| 42529542 | CARDIOVASCULAR COMPLICATIONS OF CHEMOTHERAPY IN BREAST CANCER: A SCOPING REVIEW. | Ann Ib Postgrad Med | 2026 | https://conductscience.org/library/papers/42529542 | PubMed |
| 42393712 | The mitochondrial protease, LonP1, is a potential cardioprotective target for attenuating doxorubicin-induced cardiomyocyte death. | J Transl Med | 2026 | https://conductscience.org/library/papers/42393712 | PubMed |
| 42389442 | Recovery from severe adriamycin-induced cardiomyopathy after prolonged intensive care in a patient with uterine leiomyosarcoma: A case report. | Exp Ther Med | 2026 | https://conductscience.org/library/papers/42389442 | PubMed |
| 42187577 | Maintenance Liposomal Doxorubicin Following Induction Doxorubicin in Soft Tissue Sarcoma: A Single-Center Observational Study. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42187577 | PubMed |
| 42133079 | Variability in anthracycline dose conversions and cardiotoxicity monitoring: insights from hospital pharmacists on institutional protocols in oncology practice. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/42133079 | PubMed |
| 42110959 | Integrated Cardio-oncology Service. | Card Fail Rev | 2026 | https://conductscience.org/library/papers/42110959 | PubMed |
| 42104397 | A novel green QbD-optimized RP-HPLC bioanalytical method for the simultaneous determination of doxorubicin and rifampicin in human plasma. | BMC Chem | 2026 | https://conductscience.org/library/papers/42104397 | PubMed |
| 42062800 | The Effects of Angiotensin Receptor Neprilysin Inhibitor on Endoplasmic Reticulum Stress in Doxorubicin-Mediated Cardiomyopathy-Associated Heart Failure Model in Rats. | J Appl Toxicol | 2026 | https://conductscience.org/library/papers/42062800 | PubMed |
| 42050190 | Integrating high-fidelity hiPSC-cardiomyocytes with AI-driven modeling for enhanced proarrhythmic risk assessment. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42050190 | PubMed |
| 42022755 | Doxorubicin exposure leads to cardiac fibroblast dysregulation and worsens fibrotic remodeling in the pathological heart. | J Mol Cell Cardiol Plus | 2026 | https://conductscience.org/library/papers/42022755 | PubMed |
| 41995966 | Targeting the Apelin-APJ Axis: A Promising Strategy to Mitigate Anthracycline-Induced Cardiotoxicity. | Cardiovasc Toxicol | 2026 | https://conductscience.org/library/papers/41995966 | PubMed |
| 41924873 | Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity. | Arterioscler Thromb Vasc Biol | 2026 | https://conductscience.org/library/papers/41924873 | PubMed |
| 41827970 | AI-Enabled Precision Echocardiography: Toward Personalized Cardiovascular Care. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41827970 | PubMed |
| 41778360 | Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling. | Histol Histopathol | 2026 | https://conductscience.org/library/papers/41778360 | PubMed |
| 41766769 | Frailty Meets Cardio-oncology: A New Frontier in Personalised Cancer Care. | Eur Cardiol | 2026 | https://conductscience.org/library/papers/41766769 | PubMed |
| 41741472 | Socioeconomic disparities in long-term heart failure risk of trastuzumab with or without anthracyclines in early-stage breast cancer: a SEER-Medicare database analysis. | NPJ Breast Cancer | 2026 | https://conductscience.org/library/papers/41741472 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/496103
GET https://conductscience.org/api/papers/v1/496103/cited_by?page=2